(Q43872465)

27 November 2017

title

Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. (English)

1 reference

27 November 2017

0 references

Yuko Togashi

1

1 reference

27 November 2017

Hideo Umeuchi

2

1 reference

27 November 2017

Kiyoshi Okano

3

1 reference

27 November 2017

Naoki Ando

4

1 reference

27 November 2017

Yoshitaka Yoshizawa

5

1 reference

27 November 2017

Toshiyuki Honda

6

1 reference

27 November 2017

Kuniaki Kawamura

7

1 reference

27 November 2017

Takashi Endoh

8

1 reference

27 November 2017

Jun Utsumi

9

1 reference

27 November 2017

Junzo Kamei

10

1 reference

27 November 2017

Toshiaki Tanaka

11

1 reference

27 November 2017

Hiroshi Nagase

12

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

European Journal of Pharmacology

27 November 2017

published in

1 reference

27 November 2017

volume

435

1 reference

27 November 2017

issue

2-3

1 reference

27 November 2017

page(s)

259-264

1 reference

Itching after epidural and spinal opiates

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Antipruritic effect of an opiate antagonist, naloxone hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Substance P-induced histamine release in human cutaneous mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Characterization of the antinociceptive effects of TRK-820 in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Role of opioid receptors in bombesin-induced grooming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Flare and Itch Induced by Substance P in Human Skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Mast-cell heterogeneity: functional comparison of purified mouse cutaneous and peritoneal mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Scratching behavior induced by pruritogenic but not algesiogenic agents in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Allergy in long-term hemodialysis. II. Allergic and atopic patterns of a population of patients undergoing long-term hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Interaction of RO 15-4513 and ethanol on the behaviour of mice: antagonistic or additive effects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Randomised crossover trial of naltrexone in uraemic pruritus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Pruritus in dialysis patients: a neglected problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Peripheral and central mediators of itch

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901588-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01588-6

1 reference

27 November 2017

1 reference